ClinicalTrials.gg

Drug

GlyT2/5HT2A Antagonist VVZ-149 clinical trials

studies test it
13
open now
0
in phase 3
3
first study started
2013

How studies write it

Studies that test it under each name

Studies by the year they started

13 studies that test it; most in 2015 (3)

Studies that test GlyT2/5HT2A Antagonist VVZ-149, by start year
YearStudies
20131
20141
20153
20162
20171
20192
20202
20211

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
6
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 12 · Other 1

Vivozon, Inc. (11) · Vivozon Pharmaceutical Inc. (1) · Brigham and Women's Hospital (1)

Studies

Open first, then newest update. How each study uses GlyT2/5HT2A Antagonist VVZ-149 is read from its arms, and is right about nine times in ten.

Testing it · 13

Given in every arm · 1 — GlyT2/5HT2A Antagonist VVZ-149 is usual care beside what is tested